Single Brain Metastasis.

作者: David Schiff

DOI: 10.1007/S11940-001-0027-4

关键词: CraniotomyLymphomaGerminomaMedicinePerformance statusBrain metastasisDexamethasoneSurgeryCancerRadiosurgery

摘要: The management of single brain metastases has evolved substantially over the last decade. advent triple-dose contrast-enhanced MRI scans improved radiologists’ capacity to resolve small tumors, and, thereby, resulted in a declining percentage classified as single. Only 25% 30% are single; absence systemic termed solitary. Randomized trials suggest that patients not imminent danger herniation best managed initially with dexamethasone 2 4 mg administered orally twice daily. routine use prophylactic anticonvulsants is discouraged. Patients refractory progressive tumor likely prove fatal within 3 6 months should receive fractionated whole radiotherapy. highly radiosensitive primary tumors such cell lung cancer, lymphoma, and germinoma also inactive or controllable cancer good performance status benefit from addition local strategies like surgery radiosurgery Although have been compared randomized controlled trial, data results similar. Consequently, for most fall size constraints (3.5 cm smaller diameter), preferred its relatively noninvasive nature. larger cystic obstructive hydrocephalus, neurologic instability despite corticosteroids treated craniotomy. Fractionated radiation following surgical radiosurgical metastasis appears decrease risk recurrent metastasis, although it shown improve survival. We recommend patients, be resistant radiotherapy at high neurotoxicity may reasonably defer use.

参考文章(42)
Jeffrey A. Bogart, Carmen Ungureanu, Essam Shihadeh, Chung T. Chung, Gerald A. King, Samuel Ryu, Christopher Kent, Jeffrey A. Winfield, Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma. Journal of Neuro-oncology. ,vol. 44, pp. 53- 57 ,(1999) , 10.1023/A:1006285304892
Peter D. Schellinger, Hans M. Meinck, Armin Thron, Diagnostic accuracy of MRI compared to CCT in patients with brain metastases Journal of Neuro-oncology. ,vol. 44, pp. 275- 281 ,(1999) , 10.1023/A:1006308808769
G Sze, Y Kawamura, C Johnson, R Lange, R J Wolf, S N Goldberg, R J Friedland, Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. American Journal of Neuroradiology. ,vol. 19, pp. 821- 828 ,(1998)
N Cohen, G Strauss, R Lew, D Silver, L Recht, Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. Journal of Clinical Oncology. ,vol. 6, pp. 1621- 1624 ,(1988) , 10.1200/JCO.1988.6.10.1621
WT Yuh, David J Fisher, Val M Runge, Scott W Atlas, Steven E Harms, Kenneth R Maravilla, Nina A Mayr, Joan E Mollman, Ann C Price, Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. American Journal of Neuroradiology. ,vol. 15, pp. 1037- 1051 ,(1994)
Nina A Mayr, WT Yuh, Michael G Muhonen, David J Fisher, Hoang D Nguyen, James C Ehrhardt, BC Wen, JF Doornbos, DH Hussey, Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. American Journal of Neuroradiology. ,vol. 15, pp. 1053- 1061 ,(1994)
Ajay K Bindal, Rajesh K Bindal, Kenneth R Hess, Almon Shiu, Samuel J Hassenbusch, Wei Ming Shi, Raymond Sawaya, None, Surgery versus radiosurgery in the treatment of brain metastasis Journal of Neurosurgery. ,vol. 84, pp. 748- 754 ,(1996) , 10.3171/JNS.1996.84.5.0748
J. M. Levin, D. Schiff, J. S. Loeffler, H. A. Fine, P. McL. Black, P. Y. Wen, Complications of therapy for venous thromboembolic disease in patients with brain tumors Neurology. ,vol. 43, pp. 1111- 1111 ,(1993) , 10.1212/WNL.43.6.1111
P. Peretti-Viton, D. Taieb, J. M. Viton, A. Flori, X. Muracciole, V. Benguigui, G. Salamon, Contrast-enhanced magnetisation transfer MRI in metastatic lesions of the brain. Neuroradiology. ,vol. 40, pp. 783- 787 ,(1998) , 10.1007/S002340050684
Glenn E Shelinel, Luther W Bradyz, Radiation therapy for brain metastases. Journal of Neuro-oncology. ,vol. 4, pp. 219- 225 ,(1987) , 10.1007/BF00150613